Ping An Biomedical
PASW
3 hedge funds and large institutions have $27.8K invested in Ping An Biomedical in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.11% more ownership
Funds ownership: 0% → 0.11% (+0.11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$32.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$108 |
| 3 |
JP Morgan Chase
New York
|
+$62 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $27.6K | +$32.9K | +22,293 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $91 | +$108 | +73 | New |
|
|
3
JP Morgan Chase
New York
| $52 | +$62 | +42 | New |
|
PASW Hedge Fund Activity: Q3 2025 in Review
3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Ping An Biomedical (PASW) for Q3 2025, worth a combined $27.8K.
Buyers outnumbered sellers: 3 funds opened new PASW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $32.9K.
- 3 institutional investors held Ping An Biomedical (PASW) as of Q3 2025, up from 0 in Q2 2025.
- Funds reported $27.8K of Ping An Biomedical stock for Q3 2025.
- 3 funds opened new Ping An Biomedical positions in Q3 2025 and 0 closed out, a net change of +3 holders.
- The largest Ping An Biomedical buyer in Q3 2025 was Citadel Advisors, an estimated $32.9K added.
Based on aggregated 13F filings for Q3 2025.